top of page
.png)
Eyes on Pharma
Check-out What Intel Caught our Eye
EyesOn Orca, Vertex, & Ipsen Clinical Data
This week we've had EyesOn clinical data and approvals for therapies in hematology and neurology. Check out the news onVertex's gene therapy approval for patients as young as 2-years old, Orca's allogeneic cell therapies approval for GVHD, and Ipsen's neurotoxin Phase 3 data showing efficacy in both episodic and chronic migraines.
Jana Chisholm
Jul 317 min read
Cell Therapy Manufacturing Expansion
JnJ, Legend expanding cell therapy capacity.
Jana Chisholm
Apr 15, 20252 min read
bottom of page